-
Fiche publication
Date publication
mai 2017
Journal
Bulletin du cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Pr KURTZ Jean-Emmanuel
Tous les auteurs :
Kurtz JE, D'Hondt V, Lécuru F, Lhommé C
Lien Pubmed
Résumé
The prognosis of metastatic or recurrent cervical cancer remains dismal. The poor chemosensitivity of this tumor- is an issue, especially in case of recurrence in irradiated fields. Still, chemotherapy has shown some efficacy, and mostly consists in platinum-based doublets. The addition of bevacizumab to chemotherapy has been recently validated. However, most of these patients present with complex clinical situations and the treatment strategy has to be discussed in multidisciplinary tumor boards.
Mots clés
Cancer du col de l’utérus, Cervical cancer, Metastases, Métastases, Rechute, Recurrent disease, Traitement, Treatment
Référence
Bull Cancer. 2017 May;104 Suppl 1:S39-S42